Slater & Gordon Limited investigated for falsifying accounts

It goes from bad to worse for Slater & Gordon Limited (ASX:SGH) investors.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Listed law firm Slater & Gordon Limited (ASX: SGH) revealed more bad news this morning after the company admitted it's being investigated by ASIC for allegedly deliberately falsifying its accounts between 1 December 2014 and 29 September 2015.

Investors have responded to the news by selling the shares down 6 per cent to just 25 cents this morning as the problems mount for the law firm that reported a $1 billion loss in financial year 2016.

The firm was forced to write off $879 million of the value of its purchase of Quindell's Professional Services division in the UK last year and consequently had a gross debt pile of $765 million at the end of financial year 2016.

On top of this it posted an operating cash loss of $104.2 million last year and it's no surprise its lenders have been selling its debt to private equity and distressed debt specialist firms. Macquarie Group Ltd (ASX: MQG) reportedly taking a sharp haircut on its loan by selling its debt for just 45 cents in the dollar.

Other bankers have been to the barbers after lending to the law firm and with much of the debt now in the hands of distressed debt specialists known for their adversarial approaches it seems a capital restructure to the detriment of existing shareholders is likely.

Today's news of ASIC's investigation into what are potentially serious offences in breach of the law will also heap more pressure on a board that has already turned down an offer by the chief executive to resign once before.

Currently, Slater & Gordon resembles a bonfire with ASIC, its creditors and rival fee-hungry lawyers launching class actions against it all likely to pour more fuel on to the fire over the year ahead. Buying this stock could result in a visit to the burns clinic.

Motley Fool contributor Tom Richardson owns shares of Macquarie Group Limited. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »